Vinge advised Apotea on the deal. Apotea AB (publ) completed its listing on Nasdaq Stockholm. The offering price was SEK 58 per ordinary share, corresponding to a...
You must be a Standard 1 Year member to access this content.
Vinge advised Nordic Paper on the deal. Strategic Value Partners, through Coniferous Bidco AB, executed a public takeover offer to the shareholders in Nordic Paper Holding...
You must be a Standard 1 Year member to access this content.
Vinge advised Cinclus Pharma on the deal. Cinclus Pharma Holding AB (publ) secured an offering of new ordinary shares and listing on Nasdaq Stockholm. The offering...
You must be a Standard 1 Year member to access this content.
Vinge advised Pareto Securities on the offering. Episurf Medical secured rights issue of units of up to approximately SEK 120 million. Episurf Medical is a Swedish,...
You must be a Standard 1 Year member to access this content.
Vinge advised Vimian Group AB on the offering. Vimian Group AB (publ) partly guaranteed rights issue which will provide Vimian with issue proceeds of SEK 1,633...
You must be a Standard 1 Year member to access this content.
Vinge advised Cell Impact AB on the deal. Cell Impact AB (publ) completed a rights issuance which will provide Cell Impact with issue proceeds of SEK 129...
You must be a Standard 1 Year member to access this content.
Vinge and Cravath Swaine & Moore advised Thermo Fisher Scientific Inc. on the deal, Ropes & Gray advised Summa Equity AB, Baker McKenzie advised Olink, Debevoise...
You must be a Standard 1 Year member to access this content.
Vinge advised Biotage AB on the deal. Global investment firm KKR’s life science platform Gamma Biosciences has sold Astrea Bioseparations, a company focused on helping to bring small...
You must be a Standard 1 Year member to access this content.
Vinge advised Vimian on the deal. Vimian completed a directed share issue of approximately MSEK 1,500, before issue costs. The share issue is in part based on...
You must be a Standard 1 Year member to access this content.
Orrick and Vinge advised VEF on the deal. VEF announced its listing change from Nasdaq First North Growth Market to Nasdaq Stockholm’s Main Market, which was approved...
You must be a Standard 1 Year member to access this content.
Setterwalls has advised Trill Impact on the deal. Vinge advised Cinclus Pharma. Cinclus Pharma Holding AB, a biopharmaceutical company focused on the development of a novel...
You must be a Standard 1 Year member to access this content.
Vinge and Weil, Gotshal & Manges advised MGM on the deal. Cederquist advised the Board of Directors of LeoVegas. Gernandt & Danielsson advised LeoVegas’ founders and...
You must be a Standard 1 Year member to access this content.
